BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

468 related articles for article (PubMed ID: 15791810)

  • 1. [Myelodysplastic syndrome].
    Urabe A
    Gan To Kagaku Ryoho; 2005 Mar; 32(3):287-91. PubMed ID: 15791810
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Refractory anemia and the myelodysplastic syndromes.
    Lawrence LW
    Clin Lab Sci; 2004; 17(3):178-86. PubMed ID: 15314893
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factors influencing survival in myelodysplastic syndromes in a Brazilian population: comparison of FAB and WHO classifications.
    Lorand-Metze I; Pinheiro MP; Ribeiro E; de Paula EV; Metze K
    Leuk Res; 2004 Jun; 28(6):587-94. PubMed ID: 15120935
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of five prognostic scoring systems, the French-American-British (FAB) and World Health Organization (WHO) classifications in patients with myelodysplastic syndromes: Results of a single-center analysis.
    Müller-Berndorff H; Haas PS; Kunzmann R; Schulte-Mönting J; Lübbert M
    Ann Hematol; 2006 Aug; 85(8):502-13. PubMed ID: 16715299
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Classification and scoring systems in myelodysplastic syndromes: a retrospective analysis of 311 patients.
    Navarro I; Ruiz MA; Cabello A; Collado R; Ferrer R; Hueso J; Martinez J; Miguel A; Orero MT; Pérez P; Nolasco A; Carbonell F
    Leuk Res; 2006 Aug; 30(8):971-7. PubMed ID: 16423393
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The myelodysplastic syndromes: classification and prognosis.
    Komrokji R; Bennett JM
    Curr Hematol Rep; 2003 May; 2(3):179-85. PubMed ID: 12901338
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparative review of classification systems in myelodysplastic syndromes (MDS).
    Bennett JM
    Semin Oncol; 2005 Aug; 32(4 Suppl 5):S3-10. PubMed ID: 16085011
    [TBL] [Abstract][Full Text] [Related]  

  • 8. What is in a name? Refined diagnostic criteria for prognostic assessment in myelodysplastic syndrome (MDS).
    Deeg HJ
    Leuk Res; 2004 Jun; 28(6):543-4. PubMed ID: 15120927
    [No Abstract]   [Full Text] [Related]  

  • 9. [Myelodysplastic diseases in childhood].
    Niemeyer C; Stollmann-Gibbels B; Ebell W; Gaedicke G; Creutzig U
    Klin Padiatr; 1992; 204(4):190-7. PubMed ID: 1518255
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Myelodysplastic syndrome classification].
    Ghariani I; Braham N; Hassine M; Kortas M
    Ann Biol Clin (Paris); 2013; 71(2):139-44. PubMed ID: 23587576
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined stratification of refractory anemia according to both WHO and IPSS criteria has a prognostic impact and improves identification of patients who may benefit from stem cell transplantation.
    Cermák J; Vítek A; Michalová K
    Leuk Res; 2004 Jun; 28(6):551-7. PubMed ID: 15120930
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Myelodysplastic syndromes].
    Sainty D; Horschowski N; Fossat C; Sampol J
    Ann Biol Clin (Paris); 1985; 43(6):821-30. PubMed ID: 3914223
    [No Abstract]   [Full Text] [Related]  

  • 13. Prognostic indicators and scoring systems for predicting outcome in patients with myelodysplastic syndromes.
    Aul C; Giagounidis A; Heinsch M; Germing U; Ganser A
    Rev Clin Exp Hematol; 2004 Dec; 8(2):E1. PubMed ID: 16027099
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myelodysplastic syndrome in children and adolescents.
    Niemeyer CM; Baumann I
    Semin Hematol; 2008 Jan; 45(1):60-70. PubMed ID: 18179970
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Allogeneic stem cell transplantation for adults with myelodysplastic syndromes: importance of pretransplant disease burden.
    Warlick ED; Cioc A; Defor T; Dolan M; Weisdorf D
    Biol Blood Marrow Transplant; 2009 Jan; 15(1):30-8. PubMed ID: 19135940
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The clinical implications of the World Health Organization's classification of myelodysplastic syndromes.
    Komrokji RS; Bennett JM
    Curr Hematol Rep; 2005 May; 4(3):175-81. PubMed ID: 15865868
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is International Prognostic Scoring System (IPSS) still standard in predicting prognosis in patients with myelodysplastic syndrome? External validation of the WHO Classification-Based Prognostic Scoring System (WPSS) and comparison with IPSS.
    Park MJ; Kim HJ; Kim SH; Kim DH; Kim SJ; Jang JH; Kim K; Kim WS; Jung CW
    Eur J Haematol; 2008 Nov; 81(5):364-73. PubMed ID: 18637029
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Diagnosis in the myelodysplastic syndrome].
    Hunstein W; Ho AD
    Dtsch Med Wochenschr; 1987 Jan; 112(2):60-2. PubMed ID: 3542464
    [No Abstract]   [Full Text] [Related]  

  • 19. [Myelodysplastic syndromes--new treatment options].
    Germing U
    Med Klin (Munich); 2006 Mar; 101 Suppl 1():123-6. PubMed ID: 16802536
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Myelodysplastic syndromes. A clinico-biological analysis of 27 cases].
    Mereuţă A; Turtureanu-Hanganu E
    Rev Med Chir Soc Med Nat Iasi; 1990; 94(1):67-73. PubMed ID: 2075337
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.